Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes  

作　　者：Xiaoling Cai Chu Lin Linong Ji 

机构地区：[1]Department of Endocrine and Metabolism,Peking University People’s Hospital,Beijing 100044,China

出　　处：《Chinese Medical Journal》2022年第21期2605-2607,共3页中华医学杂志（英文版）

摘　　要：To the Editor:The global prevalence of diabetes is increasing dramatically.[1]To prevent and treat diabetes and its cardiovascular complications,clinical practice guidelines recommend to assess the prevalent nonmodifiable risk factors in people with diabetes.The prediction for atherosclerotic cardiovascular disease(ASCVD)risk in China(China-PAR)model was specifically developed to predict the 10-year risk for ASCVD in China.

关 键 词：CARDIOVASCULAR DIABETES CLINICAL 

分 类 号：R587.2[医药卫生—内分泌] R54[医药卫生—内科学]